A new study points to positive results for an immunotherapy treatment that could be used to treat pancreatic cancer.

Prospective-trial analysis published in the Journal of the National Cancer Institute predicts residual cancer burden from ...

It's not often that a pathologist gets to make a diagnosis that works for the patient by preventing treatment from occurring.

LRK-4189, which targets PIP4K2C, a key cancer cell fitness target, is being developed for microsatellite stable (MSS) ...

Deep inside your nervous system, a tiny fault in how cells make energy can quietly change the course of a life. That hidden ...

Paper in @ModernPathology (bit.ly/4ouqhoe) defines the OSET, a slow-growing, benign tumor w/ a bony shell that can be mistaken for malignancy. “A misdiagnosis could result in a patient receiving ...

A new study demonstrates that replicative senescence depends upon ATM kinase, and that high oxygen generates a hyperactive ...

This was not the first presentation on STI-571, but it was the one that would change everything: The New England Journal of ...

This study presents a large, systematically curated catalog of non-canonical open reading frames (ncORFs) in human and mouse by reanalyzing nearly 400 Ribo-seq datasets using a standardized pipeline; ...

Kymera Therapeutics, Inc. ( KYMR) Citi Annual Global Healthcare Conference 2025 December 3, 2025 11:15 AM EST ...

Learn how Ignota Labs is addressing drug toxicity challenges through AI, aiming to revive effective yet shelved drugs.

Scientists discovered that the first 100 base pairs of human genes are unusually prone to mutations, especially during the earliest stages of embryonic development. These mosaic mutations often go ...